[Predictive factors of post-transplant hypertension in kidney transplant recipients].

IF 0.9 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Orvosi hetilap Pub Date : 2024-05-12 DOI:10.1556/650.2024.33039
Márton Harsányi, Reza Amir Manafzadeh, Csilla Keresztes, Máté Seregély, Bernadett Borda
{"title":"[Predictive factors of post-transplant hypertension in kidney transplant recipients].","authors":"Márton Harsányi, Reza Amir Manafzadeh, Csilla Keresztes, Máté Seregély, Bernadett Borda","doi":"10.1556/650.2024.33039","DOIUrl":null,"url":null,"abstract":"<p><p>Introduction: Hypertension after kidney transplantation has been identified as an important risk factor for chronic allograft injury. Objective: The present study aimed to determine the prevalence and possible risk factors for post-transplant hypertension. Methods: A retrospective cohort study was conducted at our kidney transplantation unit between January 1, 2007 and August 19, 2022, by including patients who regularly underwent home blood pressure monitoring. The recipient’s demographic information, laboratory data, and donor characteristics were collected at 6 and 12 months after transplantation. Blood pressure thresholds were defined according to the European Society of Hypertension (ESH) guidelines. Logistic regression was used to estimate both the unadjusted and adjusted odds ratio to identify the potential risk factors for post-transplant hypertonia and multiple imputation was used for missing data of the donors. Results: 280 patients were included in this study. The overall prevalence of hypertension was found to be 49.3% and 53.5% at 6 and 12 months after kidney transplantation, respectively. After multivariable adjustment, the predictive factors for hypertension 6 months after kidney transplantation were male gender (OR: 1.717, 95% CI: 1.007–2.927; p = 0.047) and donor with a medical history of hypertension (OR: 2.038, 95% CI: 1.038–4.004; p = 0.039). However, serum uric acid level (OR: 1.004, 95% CI: 1.000–1.007; p = 0.033) and male gender (OR: 2.048, 95% CI: 1.161–3.614; p = 0.013) were independent risk factors at 12 months. Discussion: The prevalence of hypertension is high among kidney-transplant recipients. Our study suggests that male gender, hypertensive donor, and serum uric acid level are the potential predictors of hypertension after kidney transplantation. Conclusion: Unrecognized and untreated post-transplant hypertension leads to functional deterioration of the allograft, thereby reducing graft survival. Orv Hetil. 2024; 165(19): 734–741.</p>","PeriodicalId":19911,"journal":{"name":"Orvosi hetilap","volume":"165 19","pages":"734-741"},"PeriodicalIF":0.9000,"publicationDate":"2024-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orvosi hetilap","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1556/650.2024.33039","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Hypertension after kidney transplantation has been identified as an important risk factor for chronic allograft injury. Objective: The present study aimed to determine the prevalence and possible risk factors for post-transplant hypertension. Methods: A retrospective cohort study was conducted at our kidney transplantation unit between January 1, 2007 and August 19, 2022, by including patients who regularly underwent home blood pressure monitoring. The recipient’s demographic information, laboratory data, and donor characteristics were collected at 6 and 12 months after transplantation. Blood pressure thresholds were defined according to the European Society of Hypertension (ESH) guidelines. Logistic regression was used to estimate both the unadjusted and adjusted odds ratio to identify the potential risk factors for post-transplant hypertonia and multiple imputation was used for missing data of the donors. Results: 280 patients were included in this study. The overall prevalence of hypertension was found to be 49.3% and 53.5% at 6 and 12 months after kidney transplantation, respectively. After multivariable adjustment, the predictive factors for hypertension 6 months after kidney transplantation were male gender (OR: 1.717, 95% CI: 1.007–2.927; p = 0.047) and donor with a medical history of hypertension (OR: 2.038, 95% CI: 1.038–4.004; p = 0.039). However, serum uric acid level (OR: 1.004, 95% CI: 1.000–1.007; p = 0.033) and male gender (OR: 2.048, 95% CI: 1.161–3.614; p = 0.013) were independent risk factors at 12 months. Discussion: The prevalence of hypertension is high among kidney-transplant recipients. Our study suggests that male gender, hypertensive donor, and serum uric acid level are the potential predictors of hypertension after kidney transplantation. Conclusion: Unrecognized and untreated post-transplant hypertension leads to functional deterioration of the allograft, thereby reducing graft survival. Orv Hetil. 2024; 165(19): 734–741.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[肾移植受者移植后高血压的预测因素]。
肾移植后高血压已被确定为慢性同种异体移植损伤的重要危险因素。目的:本研究旨在确定移植后高血压的患病率和可能的危险因素。方法:2007年1月1日至2022年8月19日,在我们的肾移植部门进行了一项回顾性队列研究,包括定期进行家庭血压监测的患者。在移植后6个月和12个月收集受者的人口统计信息、实验室数据和供者特征。根据欧洲高血压学会(ESH)指南定义血压阈值。采用Logistic回归估计未调整和调整后的优势比,以确定移植后高渗的潜在危险因素,并对供者的缺失数据采用多重归算。结果:280例患者纳入本研究。在肾移植后6个月和12个月,高血压的总体患病率分别为49.3%和53.5%。多变量校正后,肾移植术后6个月高血压的预测因素为男性(OR: 1.717, 95% CI: 1.007-2.927;p = 0.047)和有高血压病史的供者(OR: 2.038, 95% CI: 1.038 ~ 4.004;P = 0.039)。然而,血清尿酸水平(OR: 1.004, 95% CI: 1.000-1.007;p = 0.033)和男性(OR: 2.048, 95% CI: 1.161-3.614;P = 0.013)是12个月时的独立危险因素。讨论:在肾移植受者中高血压的患病率很高。我们的研究表明,男性、高血压供体和血清尿酸水平是肾移植后高血压的潜在预测因素。结论:未被识别和治疗的移植后高血压可导致同种异体移植物功能恶化,从而降低移植物存活率。奥夫·海泰尔。2024;165(19): 734 - 741。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Orvosi hetilap
Orvosi hetilap MEDICINE, GENERAL & INTERNAL-
CiteScore
1.20
自引率
50.00%
发文量
274
期刊介绍: The journal publishes original and review papers in the fields of experimental and clinical medicine. It covers epidemiology, diagnostics, therapy and the prevention of human diseases as well as papers of medical history. Orvosi Hetilap is the oldest, still in-print, Hungarian publication and also the one-and-only weekly published scientific journal in Hungary. The strategy of the journal is based on the Curatorium of the Lajos Markusovszky Foundation and on the National and International Editorial Board. The 150 year-old journal is part of the Hungarian Cultural Heritage.
期刊最新文献
[The symptoms of burnout and possible interpretations among the healthcare workers of the Emergency Department in Szentes]. [György Heisler, who first promoted variolation in Hungarian language in 1791]. [Analysis of pharmaceutical utilization data of strong opioids prescribed for baseline and breakthrough cancer pain in Hungary]. [Psychotropic drug-induced obesity in older adults: complications, preventive and therapeutic interventions]. [Bullous pemphigoid and primary biliary cholangitis, a rare association with therapeutic challenge].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1